EBOLA/EVD [to 13 February 2016]
Public Health Emergency of International Concern (PHEIC); “Threat to international peace and security” (UN Security Council)

.

Ebola Situation Reports
[While no announcement of a change in reporting cycle is evident, we deduce that Ebola Situation Reports have been reduced to a bi-weekly cycle given the spacing of the last few reports (last update at 3 February 2016)]

.
Gavi [to 13 February 2016]
http://www.gavialliance.org/library/news/press-releases/
11 February 2016
Japan commits US$ 18.5 million to support immunisation in Ebola-affected region
Pledge from G7 President will help revitalise immunisation services and strengthen health systems.
TOKYO, 10 February 2016 – The Government of Japan has committed US$ 18.5 million to help Gavi restore immunisation services in Ebola-affected countries. The contribution, which is for 2016 and is Japan’s largest to Gavi to date, will also support the strengthening of health systems in 13 countries, including Guinea, Liberia and Sierra Leone, where thousands of children missed out on routine vaccinations during the Ebola outbreak.

State Minister for Foreign Affairs, Seiji Kihara, made the announcement ahead of a meeting in Tokyo last Thursday with new Gavi Board Chair Dr Ngozi Okonjo-Iweala. Japan’s commitment means that all members of the G7, which will be chaired this year by Japan, have now made pledges to Gavi to support childhood immunisation for the 2016 to 2020 period.

Japan’s contribution will help Gavi support work to trace children who missed out on immunisation in the Ebola-hit countries and ensure they are reached through catch-up programmes. The new funding will also help strengthen health systems in the Ebola-affected West Africa region, including purchasing new cold chain equipment to ensure vaccines are stored at the correct temperatures…

.
EDCTP [to 13 February 2016]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
Ebola grantees have begun collaborations
12 February 2016
Grantees recently selected to conduct a range of research from basic science to implementation research, including capacity development and models of clinical care, have met for an Ebola Virus Disease (EVD) workshop on 10-11 February 2016 in Ghana to share their planned studies, identify collaborations and finalise project plans.

Six grantees are funded by the European & Developing Countries Clinical Trials Partnership (EDCTP), UK Medical Research Council (MRC), National Health Research Institute Carlos III, and the Special Programme for Research and Training in Tropical Diseases (TDR). Another 12 grantees are funded from a separate Canadian Institutes of Health Research (CIHR) grant competition. Coordination between the funders on these calls for proposals from which successful projects have been funded is in keeping with the objectives of the GLOPID-R (Global Research Collaboration for Infectious Diseases Preparedness), and culminated in the organisation of this workshop, bringing 32 collaborators from the 18 grantees together. Each project contains collaborations between African and northern institutions (Europe and Canada).